Study of CM326 for moderate to severe asthma
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests an investigational drug called CM326 for people with moderate to severe asthma that is not well controlled with current treatments. It aims to see if CM326 can help reduce asthma attacks and improve breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old and weigh at least 40 kg (about 88 pounds).
- You have been diagnosed with asthma for at least 1 year.
- Your asthma is not well controlled despite using medium to high dose inhaled steroids plus another controller medicine (like a long-acting bronchodilator) for at least 3 months.
- Your lung function (FEV1) is 80% or less of normal before using a rescue inhaler, and you have had a positive bronchodilator test in the past 2 years.
- You have had at least one severe asthma attack in the past year (but not in the last 30 days).
- You have not used certain biologic drugs, systemic steroids (except for asthma), or live vaccines within a specific time before joining.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests CM310 to see if it can improve asthma in people with moderate to severe asthma who are still having uncontrolled symptoms and severe flare-ups despite regular inhaler treatment. You may be eligible if your lung function and asthma control tests fit the study limits and you’ve had a recent severe exacerbation.
This study tests a new injected medicine (RC1416) for people with moderate-to-severe asthma that is not well controlled with daily inhalers. It may help reduce asthma attacks and improve breathing.
This trial tests a new drug called IBI3002 for people with moderate to severe asthma that isn't well controlled with standard inhalers. It aims to see if the drug is safe and tolerable when given multiple times.
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
This trial tests a new inhaled medication called LQ036 to see if it can help people whose asthma is not well controlled with their current inhalers. Participants must have had at least one severe asthma flare-up in the last year and show signs of airway inflammation.
This trial tests a new medicine called CM326 for people with moderate to severe COPD. It aims to see if the drug can reduce flare-ups and improve lung function.
Hear when a new Moderate to Severe Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.